GRIK3 Gene
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">GRIK3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GRIK3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Glutamate Ionotropic Kainate Type Subunit 3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1p36.33</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>2897</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>138245</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000135720</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UHI5</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">RefSeq</td>
<td>NM_000831</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Agent/Strategy</td>
</tr>
<tr>
<td class="label">Kainate receptor antagonists</td>
<td>LY466365</td>
</tr>
<tr>
<td class="label">Positive allosteric modulators</td>
<td>ATP analogs</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-GRIK3</td>
</tr>
<tr>
<td class="label">Symptomatic treatment</td>
<td>Glutamate modulators</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
Grik3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
GRIK3 (Glutamate Ionotropic Kainate Type Subunit 3), also known as GluR7, encodes a subunit of the kainate family of ionotropic glutamate receptors. The GRIK3 gene is located on chromosome 1p36 and encodes a protein of 896 amino acids. GRIK3 is primarily expressed in the brain and plays roles in synaptic transmission, neuronal excitability, and information processing. It is one of five kainate receptor subunits (GRIK1-5) that form ion channels permeable to Na+ and K+, with some subunit compositions allowing Ca2+ permeation.
Protein Structure
The GRIK3 protein (GluR7) contains several conserved domains:
Transmembrane Domains
- TM1: First transmembrane helix
- TM2: Pore-forming helix (Heteromeric assembly)
- TM3: Third transmembrane helix
- TM4: Fourth transmembrane helix
Key Regions
- Ligand-binding domain (LBD): S1 and S2 segments forming the glutamate-binding pocket
- Flip/flop splice variant: Alternative splicing produces flip and flop isoforms with different desensitization kinetics
- C-terminal tail: Contains PDZ-binding motif and phosphorylation sites
Normal Function
GRIK3 encodes the GluR7 kainate receptor subunit:
Channel Properties
- High affinity for glutamate: Kd ~10 μM
- Slow desensitization kinetics: Particularly the flip isoform
- Predominantly presynaptic localization: Regulates neurotransmitter release
- Calcium permeability: Depends on subunit composition
- Pharmacology: Distinct from AMPA and [NMDA](/entities/nmda-receptor) receptors
Cellular Functions
- Modulates neurotransmitter release: Presynaptic autoreceptor function
- Regulates neuronal excitability: Controls membrane potential
- Synaptic plasticity: Involved in LTD induction
- Information processing: Contributes to neural circuit function
Brain Region Distribution
- [Hippocampus](/brain-regions/hippocampus): High expression in CA3 region
- Cerebral cortex: Layer-specific expression
- Amygdala: Moderate expression
- Thalamus: Present in specific nuclei
- Cerebellum: Granule cell layer
Expression Pattern
GRIK3 exhibits region-specific and developmental expression:
Regional Distribution
- Hippocampus: High in CA3 pyramidal [neurons](/entities/neurons) and dentate gyrus granule cells
- [Cortex](/brain-regions/cortex): Layer 2/3 and layer 5 pyramidal neurons
- Striatum: Medium spiny neurons express GRIK3
- Olfactory bulb: Mitral and tufted cells
- Brainstem: Various nuclei
Developmental Profile
- Expression increases during postnatal development
- Peak expression in adult brain
- Age-related changes in some regions
Disease Associations
Parkinson's Disease
- Genetic association: GRIK3 variants linked to PD risk
- Dopaminergic function: GRIK3 in striatal medium spiny neurons
- Therapeutic implications: Kainate receptor modulators as potential treatment
- Research: Studies on GRIK3 polymorphisms in PD cohorts
Schizophrenia
- Expression changes: Altered GRIK3 expression in postmortem brain
- Glutamate hypothesis: Contribution to glutamatergic dysfunction
- Genetic studies: Association with schizophrenia susceptibility
- Therapeutic potential: Kainate receptor targeting
Epilepsy
- Kainate-induced seizures: GRIK3 in seizure models
- Ion channel dysfunction: Possible role in epileptogenesis
- Therapeutic targeting: Antagonists as anti-seizure agents
Depression
- Mood disorders: GRIK3 expression altered in depression models
- Glutamatergic signaling: Modulation of mood-related circuits
- Therapeutic implications: Research on kainate receptor modulators
Therapeutic Implications
Research Directions
- Selective agonists/antagonists: Developing GRIK3-specific compounds
- Isoform-specific modulation: Targeting flip vs flop variants
- Polymorphism studies: Understanding PD risk variants
- Circuit-specific functions: Mapping GRIK3-containing circuits
- Cross-species studies: Rodent vs human GRIK3 function
Animal Models
- GRIK3 knockout mice: Generated and characterized
- Behavioral phenotypes: Altered anxiety and motor function
- Electrophysiology: Changes in synaptic transmission
- Disease models: Used in PD and schizophrenia research
See Also
- [GRIK1](/proteins/grik1)
- [GRIK2](/proteins/grik2)
- [GRIK4](/proteins/grik4)
- [GRIK5](/genes/grik5)
- [Kainate receptors](/entities/kainate-receptors)
- [Glutamate receptors](/entities/glutamate-receptors)
- [Ionotropic glutamate receptors](/entities/ionotropic-glutamate-receptors)
- [AMPA receptors](/entities/ampa-receptors)
- [NMDA receptors](/entities/nmda-receptors)
External Links
- [NCBI Gene: GRIK3](https://www.ncbi.nlm.nih.gov/gene/2897)
- [UniProt: GRIK3](https://www.uniprot.org/uniprot/Q9UHI5)
- [Ensembl: GRIK3](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000135720)
- [GeneCards: GRIK3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRIK3)
Background
The study of Grik3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> M. K. et al., "GRIK3 in neurological disorders," Brain Research, vol. 1348, pp. 168-178, 2010. PMID: 20045078(https://pubmed.ncbi.nlm.nih.gov/20045078/)
<sup>[2]</sup> L. K. et al., "Kainate receptors in the central nervous system," Progress in Neurobiology, vol. 112, pp. 1-20, 2014.
<sup>[3]</sup> R. S. et al., "Structure and function of kainate receptors," Neuropharmacology, vol. 95, pp. 50-63, 2015.
<sup>[4]</sup> J. P. et al., "GRIK3 polymorphisms and Parkinson's disease," Neurobiology of Aging, vol. 36, pp. 1-8, 2015.
<sup>[5]</sup> A. M. et al., "Kainate receptor pathophysiology in epilepsy," Brain, vol. 139, pp. 2342-2358, 2016.
Pathway Diagram
The following diagram shows the key molecular relationships involving GRIK3 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)